Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Acta Neuropathol. 2015 Jan 21;129(3):449–457. doi: 10.1007/s00401-015-1389-0

Table 1. Clinical characteristics of matched primary and metastatic medulloblastoma in the discovery and validation cohorts.

HuGene2.0 Gene Expression (n=9) 450K DNA Methylation (n=11) Validation Tissue Microarray (n=19)

Variable No. % No. % No. %
Age, years
 ≤ 5 1 11 1 9 5 26
 5-18 5 56 6 55 11 58
 ≥18 1 11 1 9 3 16
 Unknown 2 22 3 27 0 0

Sex
 Male 3 33 4 36 10 53
 Female 4 44 4 36 9 47
 Unknown 2 22 3 28 0 0

Subgroup
 WNT 0 0 0 0 0 0
 SHH 1 11 1 9 4 21
 Group 3 2 22 3 27 8 42
 Group 4 6 67 7 64 7 37
 Unknown 0 0 0 0 0 0

Histology
 Classic 3 22 3 27 N/A
 Desmoplastic 0 0 0 0 N/A
 Large Cell Anaplastic 1 11 1 9 N/A
 Unknown 5 67 7 64 N/A

Died of disease
 No 1 11 2 18 4 21
 Yes 4 44 3 27 15 79
 Unknown 4 44 6 55 0 0
*

8/12 samples have both gene expression and 450K DNA methylation data